Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Abbvie lowers guidance after $150 million charge
05:21pm, Wednesday, 05'th Apr 2023
Abbvie Inc. ABBV, +0.64% late Wednesday lowered its guidance for the year to include a charge of about $150 million. The pharma company said GAAP as well as adjusted earnings for its first quarter are
Final Trades: Abbvie, Thermo Fisher & more
01:57pm, Wednesday, 05'th Apr 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Better Dividend Stock: AbbVie vs. Johnson & Johnson
08:55am, Wednesday, 05'th Apr 2023
Both healthcare giants are among the most elite dividend stocks on the market. AbbVie can handle the biosimilar challenges to Humira without it breaking the company.
Want to Collect Big Dividends Each Month? Buy These 3 Stocks
06:10am, Wednesday, 05'th Apr 2023
AbbVie's drug portfolio and pipeline bode well for future growth. Consumers value experiences more than stuff, which could benefit VICI Properties and its tenants.
A Look at Bernard Horn's Top Holdings Ahead of Value Conference
04:25pm, Tuesday, 04'th Apr 2023
With the goal of generating strong risk-adjusted returns and capital appreciation, Bernard Horn (Trades, Portfolio)'s Polaris Capital Management invests in discounted but high-quality stocks in develo
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:39am, Monday, 03'rd Apr 2023
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
These 5 High-Yield Dividend Stocks Should Make Me $3,000 in Passive Income This Year
05:50am, Sunday, 02'nd Apr 2023
Five stocks should generate an average yield of 8.45% on an investment of around $36,100. In addition to high dividend yields, these stocks offer attractive valuations and long-term growth prospects.
Could This Drug News Lift AbbVie's Stock?
09:15am, Saturday, 01'st Apr 2023
Rinvoq recently moved into phase 3 clinical trials for what could be its seventh indication. If approved, it could generate almost $400 million in additional yearly revenue for the drugmaker.
My Top 10 High Dividend Yield Stocks To Invest In April 2023
02:00pm, Friday, 31'st Mar 2023
In today's article, I will present you with my top 10 high Dividend Yield stocks to invest in for April 2023. The 10 selected picks provide you with an attractive Dividend Yield, a relatively low Payo
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
08:50am, Friday, 31'st Mar 2023
Skyrizi's recently announced phase 3 clinical trial results to treat ulcerative colitis demonstrate that it is effective. An ulcerative colitis indication in the U.S. could be a blockbuster all on its
2 High-Yielding Dividend Investments to Buy for the Long Haul
07:45am, Thursday, 30'th Mar 2023
Coca-Cola and AbbVie are two solid investments that pay more than 3% in dividends. Coca-Cola's growth rate has been impressive at a challenging time, and is well above its 10-year high.
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
02:00pm, Wednesday, 29'th Mar 2023
Vertex and AbbVie both beat the bear market last year. Both these top companies have reached an important moment in their stories -- and more growth may be on the horizon.
Better Growth Stock: AbbVie vs. Pfizer
07:30am, Wednesday, 29'th Mar 2023
AbbVie might not grow much in 2023 and 2024. Pfizer will see tens of billions of its sales evaporate soon.
Selecting Dividend Aristocrats Using SCHD Methodology - Mounting A Comeback
11:02am, Tuesday, 28'th Mar 2023
I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process an
Best Stocks To Buy Today? 3 Top Dividend Stocks To Watch
10:43am, Tuesday, 28'th Mar 2023
Top dividend stocks to watch this week.
